Results 231 to 240 of about 622,272 (313)

Failure to get into substance abuse treatment. [PDF]

J Subst Abuse Treat, 2017
Fisher DG, Reynolds GL, D'Anna LH, Hosmer DW, Hardan-Khalil K.   +4 more
europepmc   +1 more source

Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT In Attention Deficit Hyperactivity Disorder (ADHD), methylphenidate is one of the most widely used drugs, in which patient response significantly impacts prognosis. This study aimed to characterize the molecular profile of 10 genes associated with methylphenidate therapy.
Aline Pasquini Santos, Tatiane Carinta de Souza, Kaio Evandro Cardoso Aguiar, Ana Caroline Alves da Costa, Natasha Monte, Juliana Carla Gomes Rodrigues, Giovanna Gilioli da Costa Nunes, Rita de Cássia Calderaro Coelho, Ândrea Ribeiro‐dos‐Santos, André Maurício Ribeiro dos Santos, Sandro José de Souza, Sidney Emanuel Batista dos Santos, Rommel Mario Rodriguez Burbano, Marianne Rodrigues Fernandes, Ney Pereira Carneiro dos Santos   +14 more
wiley   +1 more source

Seroprevalence and Risk Factors for Hepatitis B, Hepatitis C, and HIV in a Substance Abuse Treatment Center

Hatice Burcu AÇIKALIN ARIKAN, Nesrin Türker, Başak Bağcı, Seval ÇALIŞKAN PALA   +3 more
openalex   +2 more sources

Employment Type and Length of Stay in Substance Abuse Treatment: Economic Factors and Gender Specific Effects

, 2013
Quinn Keefer
openalex   +2 more sources

The Elimination of Abuse and Dependence in DSM-5 Substance Use Disorders: What Does This Mean for Treatment? [PDF]

, 2014
Albert M. Kopak, Steven L. Proctor, Norman G. Hoffmann   +2 more
openalex   +1 more source

Schizophrenia Genetics Modulates Clinical Depressive Features

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT Schizophrenia (SCZ) genetic liability, quantified by polygenic scores (PGS), may influence clinical phenotypes in major depressive disorder (MDD). We investigated the effect of the SCZ‐PGS derived from the latest SCZ genome‐wide association study (GWAS) on MDD symptom severity, comorbidities, and treatment outcomes.
Alessandro Serretti, Daniel Souery, Siegfried Kasper, Joseph Zohar, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Raffaele Ferri, Giuseppe Fanelli, Chiara Fabbri, Raffaella Zanardi, Francesco Benedetti, Bernhard T. Baune, Julien Mendlewicz   +13 more
wiley   +1 more source

A current re-examination of racial/ethnic disparities in the use of substance abuse treatment: Do disparities persist? [PDF]

Drug Alcohol Depend, 2019
Pinedo M.
europepmc   +1 more source

Trauma‐Informed Practice in Welfare‐to‐Work and Employment Services: A Scoping Review

Australian Journal of Social Issues, EarlyView.
ABSTRACT There is increasing recognition within welfare services, including employment services, that many participants may have histories of trauma. Research suggests that experiences of trauma not only impact individuals' psychosocial health but also vocational elements such as job performance, employability, career progression, and financial ...
Emily Corbett, Michael McGann, Mark Considine, René Rejón   +3 more
wiley   +1 more source

Corrigendum to Employees' attitudes towards welfare technology in substance abuse treatment in Finland. [PDF]

Nordisk Alkohol Nark, 2019
europepmc   +1 more source

The Relationship Between Substance Abuse Performance Measures and Mutual-Help Group Participation after Treatment

, 2012
Gail K. Strickler, Sharon Reif, Constance M. Horgan, Andrea Acevedo   +3 more
openalex   +2 more sources